Calcium channels and associated receptors in malignant brain tumor therapy

Molecular Pharmacology

Volumn 90, Issue 3, 2016, Pages 403-409

  Morrone, Fernanda B ^a   Gehring, Marina P ^a,b   Nicoletti, Natália F ^a,c  

^a Pontifícia Universidade Católica do RS ^*  (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF CAXIAS DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; PURINERGIC P2X7 RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL; VOLTAGE GATED CALCIUM CHANNEL; ADENOSINE TRIPHOSPHATE; CELL SURFACE RECEPTOR;

CANCER GROWTH; CANCER INHIBITION; CANCER THERAPY; CELL MIGRATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR MICROENVIRONMENT; BIOLOGICAL MODEL; BRAIN NEOPLASMS; CHANNEL GATING; DRUG EFFECTS; METABOLISM;

ADENOSINE TRIPHOSPHATE; BRAIN NEOPLASMS; CALCIUM CHANNELS; HUMANS; ION CHANNEL GATING; MODELS, BIOLOGICAL; RECEPTORS, CELL SURFACE;

EID: 84984825604     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.116.103770     Document Type: Review

References (94)

1. Adinolfi E, Cirillo M, Woltersdorf R, Falzoni S, Chiozzi P, Pellegatti P, Callegari MG, Sandonà D, Markwardt F, Schmalzing G, et al. (2010) Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. FASEB J 24: 3393-3404.
2. Adinolfi E, Raffaghello L, Giuliani AL, Cavazzini L, Capece M, Chiozzi P, Bianchi G, Kroemer G, Pistoia V, and Di Virgilio F (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72:2957-2969.
3. Agostini RM, do Nascimento Pinheiro AC, Binda NS, Romano Silva MA, do Nascimento Cordeiro M, Richardson M, Sena Guimarães AL, and Gomez MV (2011) Phoneutria spider toxins block ischemia-induced glutamate release and neuronal death of cell layers of the retina. Retina 31:1392-1399.
4. Alptekin M, Eroglu S, Tutar E, Sencan S, Geyik MA, Ulasli M, Demiryurek AT, and Camci C (2015) Gene expressions of TRP channels in glioblastoma multiforme and relation with survival. Tumour Biol 36:9209-9213.
5. Amenta F, Lanari A, Mignini F, Silvestrelli G, Traini E, and Tomassoni D (2009) Nicardipine use in cerebrovascular disease: A review of controlled clinical studies. J Neurol Sci 283:219-223.
6. Amoroso F, Capece M, Rotondo A, Cangelosi D, Ferracin M, Franceschini A, Raffaghello L, Pistoia V, Varesio L, and Adinolfi E (2015) The P2X7 receptor is a key modulator of the PI3K/GSK3b/VEGF signaling network: Evidence in experimental neuroblastoma. Oncogene 34:5240-5251.
7. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, and Becchetti A (2009) Targeting ion channels in cancer: A novel frontier in antineoplastic therapy. Curr Med Chem 16:66-93.
8. Baricordi OR, Melchiorri L, Adinolfi E, Falzoni S, Chiozzi P, Buell G, and Di Virgilio F (1999) Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J Biol Chem 274:33206-33208.
9. Becchetti A (2011) Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. Am J Physiol Cell Physiol 301:C255-C265.
10. Bian S, Sun X, Bai A, Zhang C, Li L, Enjyoji K, Junger WG, Robson SC, and Wu Y (2013) P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death. PLoS One 8:e60184.
11. Bianco F, Colombo A, Saglietti L, Lecca D, Abbracchio MP, Matteoli M, and Verderio C (2009) Different properties of P2X(7) receptor in hippocampal and cortical astrocytes. Purinergic Signal 5:233-240.
12. Boldrini L, Giordano M, Alì G, Melfi F, Romano G, Lucchi M, and Fontanini G (2015) P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value. Oncol Lett 9:449-453.
13. Bomben VC and Sontheimer HW (2008) Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas. Cell Prolif 41:98-121.
14. Braganhol E, Kukulski F, Lévesque SA, Fausther M, Lavoie EG, Zanotto-Filho A, Bergamin LS, Pelletier J, Bahrami F, Ben Yebdri F, et al. (2015) Nucleotide receptors control IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in human glioma cells. Biochim Biophys Acta 1852:120-130.
15. Burnstock G and Di Virgilio F (2013) Purinergic signalling and cancer. Purinergic Signal 9:491-540.
16. Catterall WA and Swanson TM (2015) Structural basis for pharmacology of voltagegated sodium and calcium channels. Mol Pharmacol 88:141-150.
17. Cheewatrakoolpong B, Gilchrest H, Anthes JC, and Greenfeder S (2005) Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem Biophys Res Commun 332:17-27.
18. Chen YF, Chen YT, Chiu WT, and Shen MR (2013) Remodeling of calcium signaling in tumor progression. J Biomed Sci 20:23.
19. Costa-Junior HM, Sarmento Vieira F, and Coutinho-Silva R (2011) C terminus of the P2X7 receptor: Treasure hunting. Purinergic Signal 7:7-19.
20. Cuddapah VA and Sontheimer H (2011) Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol 301:C541-C549.
21. Cuddapah VA, Turner KL, and Sontheimer H (2013) Calcium entry via TRPC1 channels activates chloride currents in human glioma cells. Cell Calcium 53:187-194.
22. Di Virgilio F and Wiley JS (2002) The P2X7 receptor of CLL lymphocytes-a molecule with a split personality. Lancet 360:1898-1899.
23. Ding X, He Z, Zhou K, Cheng J, Yao H, Lu D, Cai R, Jin Y, Dong B, Xu Y, et al. (2010) Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst 102:1052-1068.
24. Dolphin AC (2006) A short history of voltage-gated calcium channels. Br J Pharmacol 147 (Suppl 1):S56-S62.
25. Fang J, Chen X, Zhang L, Chen J, Liang Y, Li X, Xiang J, Wang L, Guo G, Zhang B, et al. (2013) P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway. Int J Biochem Cell Biol 45:1109-1120.
26. Fiorio Pla A, Avanzato D, Munaron L, and Ambudkar IS (2012) Ion channels and transporters in cancer. 6. Vascularizing the tumor: TRP channels as molecular targets. Am J Physiol Cell Physiol 302:C9-C15.
27. Fuller SJ, Stokes L, Skarratt KK, Gu BJ, and Wiley JS (2009) Genetics of the P2X7 receptor and human disease. Purinergic Signal 5:257-262.
28. Ganau L, Paris M, Ligarotti GK, and Ganau M (2015) Management of gliomas: overview of the latest technological advancements and related behavioral drawbacks. Behav Neurol 2015:862634.
29. Gartland A, Hipskind RA, Gallagher JA, and Bowler WB (2001) Expression of a P2X7 receptor by a subpopulation of human osteoblasts. J Bone Miner Res 16:846-856.
30. Gehring MP, Kipper F, Nicoletti NF, Sperotto ND, Zanin R, Tamajusuku AS, Flores DG, Meurer L, Roesler R, Filho AB, et al. (2015) P2X7 receptor as predictor gene for glioma radiosensitivity and median survival. Int J Biochem Cell Biol 68:92-100.
31. Gehring MP, Pereira TC, Zanin RF, Borges MC, Braga Filho A, Battastini AM, Bogo MR, Lenz G, Campos MM, and Morrone FB (2012) P2X7 receptor activation leads to increased cell death in a radiosensitive human glioma cell line. Purinergic Signal 8:729-739.
32. Gendron FP, Neary JT, Theiss PM, Sun GY, Gonzalez FA, and Weisman GA (2003) Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am J Physiol Cell Physiol 284:C571-C581.
33. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, et al. (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1b-dependent adaptive immunity against tumors. Nat Med 15:1170-1178.
34. Gómez-Villafuertes R, García-Huerta P, Díaz-Hernández JI, and Miras-Portugal MT (2015) PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions. Sci Rep 5:18417.
35. Holzer P and Izzo AA (2014) The pharmacology of TRP channels. Br J Pharmacol 171:2469-2473.
36. Jacques-Silva MC, Bernardi A, Rodnight R, and Lenz G (2004) ERK, PKC and PI3K/Akt pathways mediate extracellular ATP and adenosine-induced proliferation of U138-MG human glioma cell line. Oncology 67:450-459.
37. Keir ST, Friedman HS, Reardon DA, Bigner DD, and Gray LA (2013) Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model. J Neurooncol 111:97-102.
38. Lang F and Stournaras C (2014) Ion channels in cancer: future perspectives and clinical potential. Philos Trans R Soc Lond B Biol Sci 369:20130108.
39. Leanza L, Managò A, Zoratti M, Gulbins E, and Szabo I (2016) Pharmacological targeting of ion channels for cancer therapy: in vivo evidences. Biochim Biophys Acta 1863 (6 Pt B):1385-1397.
40. Ledur PF, Liu C, He H, Harris AR, Minussi DC, Zhou HY, Shaffrey ME, Asthagiri A, Lopes MB, Schiff D, et al. (2016) Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells. Neuro Oncol DOI:10.1093/neuonc/now062 [published ahead of print].
41. Li S, Wang J, Wei Y, Liu Y, Ding X, Dong B, Xu Y, and Wang Y (2015) Crucial role of TRPC6 in maintaining the stability of HIF-1a in glioma cells under hypoxia. J Cell Sci 128:3317-3329.
42. Masselli M, Laise P, Tonini G, Fanelli D, Pillozzi S, Cetica V, Da Ros M, Sardi I, Buccoliero AM, Aricò M, et al. (2012) Deregulation of ion channel and transporter encoding genes in pediatric gliomas. Front Oncol 2:53.
43. Mendonça MC, Soares ES, Stávale LM, Kalapothakis E, and Cruz-Höfling MA (2014) Vascular endothelial growth factor increases during blood-brain barrier-enhanced permeability caused by Phoneutria nigriventer spider venom. BioMed Res Int 2014: 721968.
44. Mistretta F, Buffi NM, Lughezzani G, Lista G, Larcher A, Fossati N, Abrate A, Dell'Oglio P, Montorsi F, Guazzoni G, et al. (2014) Bladder cancer and urothelial impairment: The role of TRPV1 as potential drug target. BioMed Res Int 2014: 987149.
45. Montana V and Sontheimer H (2011) Bradykinin promotes the chemotactic invasion of primary brain tumors. J Neurosci 31:4858-4867.
46. Morrone FB, Horn AP, Stella J, Spiller F, Sarkis JJ, Salbego CG, Lenz G, and Battastini AM (2005) Increased resistance of glioma cell lines to extracellular ATP cytotoxicity. J Neurooncol 71:135-140.
47. Morrone FB, Jacques-Silva MC, Horn AP, Bernardi A, Schwartsmann G, Rodnight R, and Lenz G (2003) Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines. J Neurooncol 64: 211-218.
48. Morrone FB, Oliveira DL, Gamermann P, Stella J, Wofchuk S, Wink MR, Meurer L, Edelweiss MI, Lenz G, and Battastini AM (2006) In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. BMC Cancer 6:226.
49. Nabissi M, Morelli MB, Santoni M, and Santoni G (2013) Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. Carcinogenesis 34:48-57.
50. Nimmrich V and Gross G (2012) P/Q-type calcium channel modulators. Br J Pharmacol 167:741-759.
51. Noch E and Khalili K (2009) Molecular mechanisms of necrosis in glioblastoma: The role of glutamate excitotoxicity. Cancer Biol Ther 8:1791-1797.
52. Oh MC, Kim JM, Safaee M, Kaur G, Sun MZ, Kaur R, Celli A, Mauro TM, and Parsa AT (2012) Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells. PLoS One 7:e47846.
53. Omuro A and DeAngelis LM (2013) Glioblastoma and other malignant gliomas: A clinical review. JAMA 310:1842-1850.
54. Panner A, Cribbs LL, Zainelli GM, Origitano TC, Singh S, and Wurster RD (2005) Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells. Cell Calcium 37:105-19.
55. Pelegrin P and Surprenant A (2006) Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25:5071-5082.
56. Pinheiro AC, da Silva AJ, Prado MA, Cordeiro MdoN, Richardson M, Batista MC, de Castro Junior CJ, Massensini AR, Guatimosim C, Romano-Silva MA, et al. (2009) Phoneutria spider toxins block ischemia-induced glutamate release, neuronal death, and loss of neurotransmission in hippocampus. Hippocampus 19: 1123-1129.
57. Pinheiro AC, Gomez RS, Massensini AR, Cordeiro MN, Richardson M, Romano-Silva MA, Prado MA, De Marco L, and Gomez MV (2006) Neuroprotective effect on brain injury by neurotoxins from the spider Phoneutria nigriventer. Neurochem Int 49: 543-547.
58. Prevarskaya N, Skryma R, and Shuba Y (2011) Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 11:609-618.
59. Prevarskaya N, Skryma R, and Shuba Y (2013) Targeting Ca2? transport in cancer: close reality or long perspective? Expert Opin Ther Targets 17:225-241.
60. Prevarskaya N, Zhang L, and Barritt G (2007) TRP channels in cancer. Biochim Biophys Acta 1772:937-946.
61. Ransom CB, O'Neal JT, and Sontheimer H (2001) Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J Neurosci 21:7674-7683.
62. Rao VR, Perez-Neut M, Kaja S, and Gentile S (2015) Voltage-gated ion channels in cancer cell proliferation. Cancers (Basel) 7:849-875.
63. Rapôso C, Odorissi PA, Oliveira AL, Aoyama H, Ferreira CV, Verinaud L, Fontana K, Ruela-de-Sousa RR, and da Cruz-Höfling MA (2012) Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier. Neurochem Res 37:1967-1981.
64. Rigo FK, Dalmolin GD, Trevisan G, Tonello R, Silva MA, Rossato MF, Klafke JZ, Cordeiro MdoN, Castro Junior CJ, Montijo D, et al. (2013a) Effect of v-conotoxin MVIIA and Pha1b on paclitaxel-induced acute and chronic pain. Pharmacol Biochem Behav 114-115:16-22.
65. Rigo FK, Trevisan G, Rosa F, Dalmolin GD, Otuki MF, Cueto AP, de Castro Junior CJ, Romano-Silva MA, Cordeiro Mdo N, Richardson M, et al. (2013b) Spider peptide Pha1b induces analgesic effect in a model of cancer pain. Cancer Sci 104: 1226-1230.
66. Robins HI, Lassman AB, and Khuntia D (2009) Therapeutic advances in malignanglioma: current status and future prospects. Neuroimaging Clin N Am 19:647-656.
67. Roger S, Jelassi B, Couillin I, Pelegrin P, Besson P, and Jiang LH (2015) Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives. Biochim Biophys Acta 1848 (10 Pt B):2584-2602.
68. Roger S and Pelegrin P (2011) P2X7 receptor antagonism in the treatment of cancers. Expert Opin Investig Drugs 20:875-880.
69. Ryu JK, Jantaratnotai N, Serrano-Perez MC, McGeer PL, and McLarnon JG (2011) Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model. J Neuropathol Exp Neurol 70:13-22.
70. Saunders BM, Fernando SL, Sluyter R, Britton WJ, and Wiley JS (2003) A loss-offunction polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J Immunol 171:5442-5446.
71. Simon OJ, Müntefering T, Grauer OM, and Meuth SG (2015) The role of ion channels in malignant brain tumors. J Neurooncol 125:225-235.
72. Sluyter R, Dalitz JG, and Wiley JS (2004) P2X7 receptor polymorphism impairs extracellular adenosine 59-triphosphate-induced interleukin-18 release from human monocytes. Genes Immun 5:588-591.
73. Souza AH, Ferreira J, Cordeiro MdoN, Vieira LB, De Castro CJ, Trevisan G, Reis H, Souza IA, Richardson M, Prado MA, et al. (2008) Analgesic effect in rodents of native and recombinant Ph a 1b toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom. Pain 140:115-126.
74. Stock K, Kumar J, Synowitz M, Petrosino S, Imperatore R, Smith ES, Wend P, Purfürst B, Nuber UA, Gurok U, et al. (2012) Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1. Nat Med 18: 1232-1238.
75. Tamajusuku AS, Villodre ES, Paulus R, Coutinho-Silva R, Battasstini AM, Wink MR, and Lenz G (2010) Characterization of ATP-induced cell death in the GL261 mouse glioma. J Cell Biochem 109:983-991.
76. Tan G, Sun SQ, and Yuan DL (2008) Expression of Kir 4.1 in human astrocytic tumors: correlation with pathologic grade. Biochem Biophys Res Commun 367: 743-747.
77. Tomczak K, Czerwińska P, and Wiznerowicz M (2015) The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge. Contemp Oncol (Pozn) 19 (1A): A68-A77.
78. Valerie NC, Dziegielewska B, Hosing AS, Augustin E, Gray LS, Brautigan DL, Larner JM, and Dziegielewski J (2013) Inhibition of T-type calcium channels disrupts Akt signaling and promotes apoptosis in glioblastoma cells. Biochem Pharmacol 85:888-897.
79. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, and Olson JJ (2010) Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin 60:166-193.
80. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al.; Cancer Genome Atlas Research Network (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98-110.
81. Volonté C, Apolloni S, Skaper SD, and Burnstock G (2012) P2X7 receptors: channels, pores and more. CNS Neurol Disord Drug Targets 11:705-721.
82. Watkins S and Sontheimer H (2012) Unique biology of gliomas: challenges and opportunities. Trends Neurosci 35:546-556.
83. Wee S, Niklasson M, Marinescu VD, Segerman A, Schmidt L, Hermansson A, Dirks P, Forsberg-Nilsson K, Westermark B, Uhrbom L, et al. (2014) Selective calcium sensitivity in immature glioma cancer stem cells. PLoS One 9:e115698.
84. Wei W, Ryu JK, Choi HB, and McLarnon JG (2008) Expression and function of the P2X(7) receptor in rat C6 glioma cells. Cancer Lett 260:79-87.
85. Wen PY and Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359: 492-507.
86. White N and Burnstock G (2006) P2 receptors and cancer. Trends Pharmacol Sci 27: 211-217.
87. Wiley JS, Sluyter R, Gu BJ, Stokes L, and Fuller SJ (2011) The human P2X7 receptor and its role in innate immunity. Tissue Antigens 78:321-332.
88. 2+,BK channel activity and cell migration. J Biomed Sci 16:90.
89. Yamanaka R and Saya H (2009) Molecularly targeted therapies for glioma. Ann Neurol 66:717-729.
90. Yee NS (2015) Roles of TRPM8 ion channels in cancer: proliferation, survival, and invasion. Cancers (Basel) 7:2134-2146.
91. Zamponi GW, Lory P, and Perez-Reyes E (2010) Role of voltage-gated calcium channels in epilepsy. Pflugers Arch 460:395-403.
92. Zhang Y, Zhang J, Jiang D, Zhang D, Qian Z, Liu C, and Tao J (2012) Inhibition of T-type Ca2? channels by endostatin attenuates human glioblastoma cell proliferation and migration. Br J Pharmacol 166:1247-1260.
93. Zhao W, Wang L, Han H, Jin K, Lin N, Guo T, Chen Y, Cheng H, Lu F, Fang W, et al. (2013) 1B50-1, a mAb raised against recurrent tumor cells, targets liver tumorinitiating cells by binding to the calcium channel a2δ1 subunit. Cancer Cell 23: 541-556.
94. 2+entry regulates glioma cell migration and invasion via modulation of Pyk2 phosphorylation. J Exp Clin Cancer Res 33:98.